Immune checkpoint inhibitors (ICIs) have transformed cancer therapy by targeting key immune pathways such as PD-1, PD-L1, CTLA-4, and LAG-3 to enhance the immune system's ability to combat ...
METHODS: Patients with conjunctival SCC from St Vincent's ... Seven patients (27%) suffered recurrent ocular surface squamous neoplasia (OSSN) within 4-15 months and two of these patients (8% ...
No writing assistance was utilized in the production of this manuscript. Ocular surface squamous neoplasia is the most common nonpigmented ocular surface lesion. Ocular surface squamous neoplasia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback